Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: results of a prospective trial. - Perminova M; Shelikhova L; Klimentova M; Skvortsova Y; Balashov D; Ilyushina M; Shasheleva D; Khismatullina R; Shipitsina I; Maschan A; Maschan M (Bone marrow transplantation, 2025)